Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease

Alzheimer's and Dementia: Translational Research and Clinical Interventions

Volumn 2, Issue 3, 2016, Pages 182-191

  Boccardi, Virginia ^a   Baroni, Marta ^a   Mangialasche, Francesca ^b   Mecocci, Patrizia ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Aging; Alzheimer's disease; Antioxidant; Cognition; Mild cognitive impairment; Supplementation; Treatment; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; TOCOPHEROL DERIVATIVE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; COGNITION; COGNITIVE DEFECT; HUMAN; META ANALYSIS; NONHUMAN; OBSERVATIONAL STUDY; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

EID: 84988924050     PISSN: None     EISSN: 23528737     Source Type: Journal    
DOI: 10.1016/j.trci.2016.08.002     Document Type: Review

References (62)

1. [1] Evans, H.M., Bishop, K.S., On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 56 (1922), 650–651.
2. [2] Sondergaad, E., Dam, H., Influence of the level of dietary linoleic acid on the amount of d-alpha-tocopherol acetate required for protection against encephalomalcia. Z Ernahrungswiss 6 (1966), 253–258.
3. [3] Granados, H., Dam, H., On the histochemical relationship between peroxidation and the yellow-brown pigment in the adipose tissue of vitamin E-deficient rats. Acta Pathol Microbiol Scand 27 (1950), 591–598.
4. [4] Harris, P.L., Embree, N.D., Quantitative consideration of the effect of polyunsaturated fatty acid content of the diet upon the requirements for vitamin E. Am J Clin Nutr 13 (1963), 385–392.
5. [5] Wolf, G., The discovery of the antioxidant function of vitamin E: the contribution of Henry A Matill. J Nutr 135 (2005), 363–366.
6. [6] Traber, M.G., Atkinson, J., Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43 (2007), 3–15.
7. [7] Zingg, J.M., Modulation of signal transduction by vitamin E. Mol Aspects Med 28 (2007), 481–506.
8. [8] Zingg, J.M., Azzi, A., Non antioxidant activities of vitamin E. Curr Med Chem 11 (2004), 1113–1133.
9. [9] Roy, S., Lado, B.H., Khanna, S., Sen, C.K., Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett 530 (2002), 17–23.
10. [10] Rimbach, G., Minihane, A.M., Majewicz, J., Fisher, A., Pallauf, J., Virgili, F., et al. Regulation of cell signaling by vitamin E. Proc Nutr Soc 61 (2002), 415–425.
11. [11] Kolosova, N.G., Shcheglova, T.V., Sergeeva, S.V., Loskutova, L.V., Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. Neurobiol Aging 27 (2006), 1289–1297.
12. [12] Farina, N., Isaac, M.G., Clark, A.R., Rusted, J., Tabet, N., Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev, 11, 2012, CD002854.
13. [13] Sheppard, A.J., Pennington, J.A.T., Weihrauch, J.L., Analysis and distribution of vitamin E in vegetable oils and foods. Packer, L., Fuchs, J., (eds.) Vitamin E in health and disease, 1993, Marcel Dekker, Inc., New York, 9–31.
14. [14] Yap, S.P., Yuen, K.H., Wong, J.W., Pharmacokinetics and bioavailability of alpha-, gamma and delta-tocotrienols under different food status. J Pharm Pharmacol 53 (2001), 67–71.
15. [15] Mangialasche, F., Baglioni, M., Cecchetti, R., Kivipelto, M., Ruggiero, C., Piobbico, D., et al. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment. J Alzheimers Dis 44 (2015), 649–660.
16. [16] Picco, A., Polidori, M.C., Ferrara, M., Cecchetti, R., Arnaldi, D., Baglioni, M., et al. Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. Eur J Nucl Med Mol Imaging 41 (2014), 764–775.
17. [17] Mangialasche, F., Polidori, M.C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., et al. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 8 (2009), 8285–8305.
18. [18] Brigelius-Flohé, R., Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med 46 (2009), 543–554.
19. [19] Müller, L., Theile, K., Böhm, V., In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol Nutr Food Res 54 (2010), 731–742.
20. [20] Li, D., Saldeen, T., Romeo, F., Mehta, J.L., Relative effects of a- and g-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J Cardiovasc Pharmacol Ther 4 (1999), 219–226.
21. [21] Voronkov, M., Braithwaite, S.P., Stock, J.B., Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease. Future Med Chem 3 (2011), 821–833.
22. [22] Ahsan, H., Ahad, A., Iqbal, J., Siddiqui, W.A., Pharmacological potential of tocotrienols: a review. Nutr Metab (Lond), 11, 2014, 52.
23. [23] Gustaw-Rothenberg, K., Kowalczuk, K., Stryjecka-Zimmer, M., Lipids' peroxidation markers in Alzheimer's disease and vascular dementia. Geriatr Gerontol Int 10 (2010), 161–166.
24. [24] Grundman, M., Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am J Clin Nutr 71 (2000), 630S–636S.
25. [25] Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L., Wilson, R.S., Aggarwal, N.T., et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 81 (2005), 508–514.
26. [26] Hensley, K., Barnes, L.L., Christov, A., Tangney, C., Honer, W.G., Schneider, J.A., et al. Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance. J Alzheimers Dis 24 (2011), 767–774.
27. [27] Yatin, S.M., Varadarajan, S., Butterfield, D.A., Vitamin E prevents Alzheimer's amyloid-beta-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J Alzheimers Dis 2 (2000), 123–131.
28. [28] Heppner, F.L., Ransohoff, R.M., Becher, B., Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16 (2015), 358–372.
29. [29] Rota, C., Rimbach, G., Minihane, A.M., Stoecklin, E., Barella, L., Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci 8 (2005), 21–29.
30. [30] Gohil, K., Schock, B.C., Chakraborty, A.A., Terasawa, Y., Raber, J., Farese, R.V., et al. Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein. Free Radic Biol Med 35 (2003), 1343–1354.
31. [31] Giraldo, E., Lloret, A., Fuchsberger, T., Viña, J., Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E. Redox Biol 2 (2014), 873–877.
32. [32] Block, M.L., NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci, 9, 2008, S8.
33. [33] Chu, J., Praticò, D., 5-Lipoxygenase as an endogenous modulator of amyloid beta formation in vivo. Ann Neurol 69 (2011), 34–46.
34. [34] McGreer, P.L., McGreer, E.G., NSAIDs and Alzheimer disease: epidemiologic, animal model and clinical studies. Neurobiol Aging 28 (2007), 639–647.
35. [35] Goodwin, J.S., Goodwin, J.M., Garry, P.J., Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249 (1983), 2917–2921.
36. [36] Perkins, A.J., Hendrie, H.C., Callahan, C.M., Gao, S., Unverzagt, F.W., Xu, Y., et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 150 (1999), 37–44.
37. [37] Klapcinska, B., Derejczyk, J., Wieczorowska-Tobis, K., Sobczak, A., Sadowska-Krepa, E., Danch, A., Antioxidant defense in centenarians (a preliminary study). Acta Biochim Pol 47 (2000), 281–292.
38. [38] Rinaldi, P., Polidori, M.C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24 (2003), 915–919.
39. [39] Ortega, R.M., Requejo, A.M., López-Sobaler, A.M., Andrés, P., Navia, B., Perea, J.M., et al. Cognitive function in elderly people is influenced by vitamin E status. J Nutr 132 (2002), 2065–2068.
40. [40] Engelhart, M.J., Geerlings, M.I., Ruitenberg, A., van Swieten, J.C., Hofman, A., Witteman, J.C., et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 (2002), 3223–3229.
41. [41] Cherubini, A., Martin, A., Andres-Lacueva, C., Di Iorio, A., Lamponi, M., Mecocci, P., et al. Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study. Neurobiol Aging 26 (2005), 987–994.
42. [42] Ravaglia, G., Forti, P., Lucicesare, A., Pisacane, N., Rietti, E., Mangialasche, F., et al. Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort. Am J Clin Nutr 87 (2008), 1306–1313.
43. [43] Mangialasche, F., Kivipelto, M., Mecocci, P., Rizzuto, D., Palmer, K., Winblad, B., et al. High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. J Alzheimers Dis 20 (2010), 1029–1037.
44. [44] Mangialasche, F., Xu, W., Kivipelto, M., Costanzi, E., Ercolani, S., Pigliautile, M., et al. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging 332 (2012), 282–290.
45. [45] Mangialasche, F., Westman, E., Kivipelto, M., Muehlboeck, J.S., Cecchetti, R., Baglioni, M., et al. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol. J Intern Med 273 (2013), 602–621.
46. [46] Mangialasche, F., Solomon, A., Kåreholt, I., Hooshmand, B., Cecchetti, R., Fratiglioni, L., et al. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults. Exp Gerontol 48 (2013), 1428–1435.
47. [47] La Rue, A., Koehler, K.M., Wayne, S.J., Chiulli, S.J., Haaland, K.Y., Garry, P.J., Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 65 (1997), 20–29.
48. [48] Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Wilson, R.S., Vitamin E and cognitive decline in older persons. Arch Neurol 59 (2002), 1125–1132.
49. [49] Grodstein, F., Chen, J., Willett, W.C., High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 77 (2003), 975–984.
50. [50] Zandi, P.P., Anthony, J.C., Khachaturian, A.S., Stone, S.V., Gustafson, D., Tschanz, J.T., et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 61 (2004), 82–88.
51. [51] Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 336 (1997), 1216–1222.
52. [52] Petersen, R.C., Thomas, R.G., Grundman, M., Bennett, D., Doody, R., Ferris, S., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352 (2005), 2379–2388.
53. [53] Kang, J.H., Cook, N., Manson, J., Buring, J.E., Grodstein, F.A., Randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 166 (2006), 2462–2468.
54. [54] Lloret, A., Badía, M.C., Mora, N.J., Pallardó, F.V., Alonso, M.D., Viña, J., Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis 17 (2009), 143–149.
55. [55] Dysken, M.W., Sano, M., Asthana, S., Vertrees, J.E., Pallaki, M., Llorente, M., et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 311 (2014), 33–44.
56. [56] Miller, E.R. III, Pastor-Barriuso, R., Dalal, D., Riemersma, R.A., Appel, L.J., Guallar, E., Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142 (2005), 37–46.
57. [57] Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., Gluud, C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA 297 (2007), 842–857.
58. [58] Frank, J., Chin, X.W.D., Schrader, C., Eckert, G.P., Rimbach, G., Do tocotrienols have potential as neuroprotective dietary factors?. Ageing Res Rev 11 (2012), 163–180.
59. [59] Podszun, M., Frank, J., Vitamin E-drug interactions: molecular basis and clinical relevance. Nutr Res Rev 16 (2014), 1–17.
60. [60] Serbinova, E., Kagan, V., Han, D., Packer, L., Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 10 (1991), 263–275.
61. [61] Suzuki, Y.J., Tsuchiya, M., Wassall, S.R., Choo, Y.M., Govil, G., Kagan, V.E., et al. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 32 (1993), 10692–10699.
62. [62] Corbett, A., Ballard, C., The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs. Evid Based Med, 19, 2014, 140.